Under the terms of the proposed deal, Immunova, or its affiliate, would acquire the entire share capital of iOx Therapeutics, a company focused on developing liposomal iNKT agonists. iOx’s lead ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...